Search research articles
Contact Us
Filters
Showing results (281-290 of 512) with videos related to
Page
of 52
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
September 1, 1994
Flow reversal in the descending aorta: a guide to intraoperative assessment of aortic regurgitation with transesophageal echocardiography
D C Sutton, R Kluger, S U Ahmed, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
July 1, 1992
Prevalence of heart failure in three general practices in north west London
J Parameshwar, M M Shackell, A Richardson, et al.
Pharmaceutical Research
|
October 1, 1993
Enhanced bioavailability of cefoxitin using palmitoylcarnitine. II. Use of directly compressed tablet formulations in the rat and dog
S C Sutton, E L LeCluyse, K Engle, et al.
British Medical Journal
|
June 19, 1971
Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism
G A Miller, G C Sutton, I H Kerr, et al.
Psychological Medicine
|
February 20, 2004
A pragmatic cluster randomized controlled trial of an educational intervention for GPs in the assessment and management of depression
L Gask, C Dowrick, C Dixon, et al.
Pharmaceutical Research
|
August 1, 1990
Performance of diltiazem tablet and multiparticulate osmotic formulations in the dog
S C Sutton, K Engle, R A Deeken, et al.
Journal of Biological Standardization
|
January 1, 1989
Purification and sequencing of glycosylation variants of BSF-1, as a MAF, from the EL-4 leukaemia cell line
C Sutton, P Depledge, L Bawden, et al.
Developmental and Comparative Immunology
|
March 23, 2015
The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved
Kate M C Sutton, Tuanjun Hu, Zhiguang Wu, et al.
Postgraduate Medical Journal
|
February 1, 1995
ACE inhibitors in heart failure. What dose?
J G Cleland, W N Hubbard, J Pittard, et al.
Molecular Pharmaceutics
|
October 19, 2012
Solid nanocrystalline dispersions of ziprasidone with enhanced bioavailability in the fasted state
Avinash G Thombre, W Brett Caldwell, Dwayne T Friesen, et al.
Page
of 52
Search research articles
Search
Showing results (281-290 of 512) with videos related to
Sort By:
Page
of 52
The Journal of Thoracic and Cardiovascular Surgery
|
September 1, 1994
Flow reversal in the descending aorta: a guide to intraoperative assessment of aortic regurgitation with transesophageal echocardiography
D C Sutton, R Kluger, S U Ahmed, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
July 1, 1992
Prevalence of heart failure in three general practices in north west London
J Parameshwar, M M Shackell, A Richardson, et al.
Pharmaceutical Research
|
October 1, 1993
Enhanced bioavailability of cefoxitin using palmitoylcarnitine. II. Use of directly compressed tablet formulations in the rat and dog
S C Sutton, E L LeCluyse, K Engle, et al.
British Medical Journal
|
June 19, 1971
Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism
G A Miller, G C Sutton, I H Kerr, et al.
Psychological Medicine
|
February 20, 2004
A pragmatic cluster randomized controlled trial of an educational intervention for GPs in the assessment and management of depression
L Gask, C Dowrick, C Dixon, et al.
Pharmaceutical Research
|
August 1, 1990
Performance of diltiazem tablet and multiparticulate osmotic formulations in the dog
S C Sutton, K Engle, R A Deeken, et al.
Journal of Biological Standardization
|
January 1, 1989
Purification and sequencing of glycosylation variants of BSF-1, as a MAF, from the EL-4 leukaemia cell line
C Sutton, P Depledge, L Bawden, et al.
Developmental and Comparative Immunology
|
March 23, 2015
The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved
Kate M C Sutton, Tuanjun Hu, Zhiguang Wu, et al.
Postgraduate Medical Journal
|
February 1, 1995
ACE inhibitors in heart failure. What dose?
J G Cleland, W N Hubbard, J Pittard, et al.
Molecular Pharmaceutics
|
October 19, 2012
Solid nanocrystalline dispersions of ziprasidone with enhanced bioavailability in the fasted state
Avinash G Thombre, W Brett Caldwell, Dwayne T Friesen, et al.
Page
of 52